Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-22-021338
Filing Date
2022-08-25
Accepted
2022-08-25 15:25:35
Documents
1
Period of Report
2022-06-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 5065
  Complete submission text file 0001437749-22-021338.txt   6389
Mailing Address C/O KITE PHARMA, INC. 2225 COLORADO AVENUE SANTA MONICA CA 90404
Business Address
Nussbaum Ran (Reporting) CIK: 0001609805 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38079 | Film No.: 221197072

Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Issuer) CIK: 0001668243 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations